Dapsone as a cheap and safe second-line drug for chronic immune thrombocytopenia in developing countries: A prospective cohort study

Dapsone as a cheap and safe second-line drug for chronic immune thrombocytopenia in developing countries: A prospective cohort study

Objective: The aim was to evaluate the efficacy and safety profile of dapsone as a cheap second-line treatment for chronic immune thrombocytopenia (ITP) in developing countries. Materials and Methods: A prospective study on 100 chronic ITP patients. These patients were put on dapsone after ruling ou...

Full description

Bibliographic Details
Main Authors: Yasir Bashir Khan, Asif Ahmed, Syed Sajad Geelani, Shabeer Ahmad Mir, Javid Rasool Bhat, Nusrat Bashir, Javeed Iqbal Bhat
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Journal of Applied Hematology
Subjects:
Dapsone
immune thrombocytopenia
treatment
Online Access:http://www.jahjournal.org/article.asp?issn=1658-5127;year=2014;volume=5;issue=3;spage=86;epage=90;aulast=Khan

Internet

http://www.jahjournal.org/article.asp?issn=1658-5127;year=2014;volume=5;issue=3;spage=86;epage=90;aulast=Khan

Similar Items